Neoadjuvant vs Perioperative Immune Checkpoint Blockade in R

Survival outcomes following curative resection in resectable NSCLC have been poor and, until recently, the main tool oncologists had at their disposal was neoadjuvant or adjuvant chemotherapy.

Related Keywords

Hollywood , California , United States , Perioperative Pembrolizumab Keytruda , Samuel Rosner , Neoadjuvant Nivolumab Opdivo , University Of Maryland Greenebaum Comprehensive Cancer Center , Annual Winter Lung , Maryland Greenebaum Comprehensive Cancer Center , Meets Primary End , Annual Winter Lung Cancer Conference , Per Winter Lung Cancer Conference , Lung Cancer , News ,